Lebenthal Holdings’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$347K Sell
1,433
-645
-31% -$170K 0.04% 290
2016
Q1
$541K Buy
2,078
+49
+2% +$12.9K 0.09% 243
2015
Q4
$621K Sell
2,029
-941
-32% -$270K 0.15% 193
2015
Q3
$867K Buy
2,970
+1,708
+135% +$564K 0.2% 165
2015
Q2
$510K Sell
1,262
-179
-12% -$71.8K 0.1% 216
2015
Q1
$608K Sell
1,441
-98
-6% -$38.6K 0.14% 197
2014
Q4
$522K Buy
+1,539
New +$498K 0.23% 117

Other funds holding BIIB

Lebenthal Holdings's BIIB Position: Q2 2016 in Review

Lebenthal Holdings reduced its Biogen (BIIB) stake by 31% in Q2 2016, selling an estimated $170K and leaving 1,433 shares worth $347K. The position accounts for 0.04% of the portfolio, ranked #290.

Lebenthal Holdings first reported a position in BIIB in Q4 2014 and has held it in 7 quarters since. The position peaked at $867K in Q3 2015. 967 funds tracked by Wall St. Rank hold BIIB as of Q2 2016.

  • Lebenthal Holdings held 1,433 shares of Biogen worth $347K as of Q2 2016.
  • Lebenthal Holdings sold 645 Biogen shares in Q2 2016, an estimated $170K.
  • Biogen made up 0.04% of Lebenthal Holdings's portfolio in Q2 2016, its #290 holding.
  • Lebenthal Holdings first reported a position in Biogen in Q4 2014 and has held it in 7 quarters since.
  • Lebenthal Holdings's Biogen position peaked at $867K in Q3 2015.
  • 967 funds tracked by Wall St. Rank held Biogen as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.